Forecast

There is no analyst data available for this company.

News Go to news feed

Tsuruha Holdings surpasses half-year targets thanks to expanding pharmacy business

Tsuruha reported net sales of ¥557.8 billion and an operating profit of ¥28.4 billion for the first half of FY2026, exceeding plan targets. Drivers included expansion of the prescription-pharmacy business, strong private-brand sales and SG&A cost control; the number of stores rose by a net 18 to 2,676. The company strengthened its liquidity ahead of the planned integration with WELCIA and the takeover completion by AEON, expected in December 2025 and January 2026, respectively. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Tsuruha Holdings Inc has already paid €0.12 in dividends. The last payout was in May.

Financials

In the last quarter, Tsuruha Holdings Inc had revenue of €3.43bn and net profit of €72.6m

(EUR)	May 2026	YoY
Revenue	3.43bn	105.79%
Gross profit	1.03bn	104.89%
Net profit	72.6m	6.79%
EBITDA	213.55m	46.26%

Fundamentals

Metric	Value
Market capitalization	€5.34bn
Number of shares	453.09m
52-week high/low	€16.84 - €10.63
Dividend yield	0.46%
Dividends TTM	€0.28
Beta	0.17
P/E ratio	16.28
PEG ratio	1.55
P/B ratio	1.08
P/S ratio	0.52

Company profile

Tsuruha Holdings Inc. betreibt Drogerien in Japan. Das Unternehmen verkauft pharmazeutische und kosmetische Produkte. Mit Stand vom 15. Oktober 2021 betrieb das Unternehmen 2.448 Geschäfte in Japan und 22 Geschäfte in Thailand. Das Unternehmen wurde 1929 gegründet und hat seinen Hauptsitz in Sapporo, Japan.